Latest Breaking News On - Corteria pharmaceuticals - Page 1 : comparemela.com

Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure

Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

France generalPhilip janiakAdriaan voorsCorteria pharmaceuticalsMenafn andrew lloyd associatesUniversity medical centre groningen netherlandsWorsening heart failureUniversity medical centre groningen

Funding steers Cardiovascular Pipeline towards Clinical Entry

Biopharma Corteria, which announced an oversubscribed €65M ($71M) Series A co-led by investment firms OrbiMed (US) and Jeito Capital (EU), will be  using the funding to advance its cardiovascular pipeline into the clinic. Click to read more.

Philip janiakThierry laugelMarie laure ozouxBiopharma corteriaErez chimovitsAndreas wallnoeferPhilip janiaCorteria pharmaceuticalsJeito capitalManaging partnerKurma partnersFountain healthcare partnersV bio venturesInvivo capitalOmnes capital

Jeito Capital co-leads EUR 65 million (USD 71 M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardi

Jeito Capital co-leads EUR 65 million (USD 711M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases

France generalUnited statesPhilip janiakAssia mouhoutMarie laure ozouxAndreas wallnoeferJeito capitaladdedJeito corteria pharmaceuticals frenchConsilium strategic communicationsBanque de franceCorteria pharmaceuticalsJeito capitalKurma partnersFountain healthcare partnersV bio venturesInvivo capital

Jeito Capital co-leads EUR 65 million (USD 71 M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases

Jeito Capital co-leads EUR 65 million (USD 71 M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited statesBaden wübergPhilip janiakAssia mouhoutMarie laure ozouxAndreas wallnoeferJeito capitaladdedJeito corteria pharmaceuticals frenchCorteria pharmaceuticalsBanque de franceJeito capitalKurma partnersFountain healthcare partnersV bio venturesInvivo capital

Jeito Capital co-leads EUR 65 million (USD 71 M) financing in Corteria Pharmaceuticals, a

Jeito Capital co-leads EUR 65 million (USD 711M) financing in

France generalUnited statesMarie laure ozouxAndreas wallnoeferAssia mouhoutPhilip janiakCorteria pharmaceuticalsBanque de franceJeito capitalKurma partnersFountain healthcare partnersV bio venturesInvivo capitalWorsening heartRight heart failureAcute heart failure